Physician profile
John J Debarros
NPI 1194767228
$2,090.60
in general payments reported to CMS, 2019-2025
15 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $58.47 · 2022: $120 · 2023: $80.90 · 2024: $1,007 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,077.02 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu A/S | $350.00 | 2024 | |
| Medtronic, INC. | $317.53 | 2022-2024 | Signia |
| Hologic Sales and Service, LLC | $293.44 | 2024 | Coolseal Generator |
| Covidien LP | $277.03 | 2019-2020 | |
| Gt Metabolic Solutions INC | $234.63 | 2025 | |
| Intuitive Surgical, INC. | $209.41 | 2019 | |
| Ethicon US, LLC | $88.85 | 2024-2025 | Echelon; Endopath, Enseal |
| Boston Scientific Corporation | $86.03 | 2023-2025 | General - Pain Management |
| Reshape Lifesciences INC. | $57.60 | 2019 | |
| Intra-Sana Laboratories | $40.82 | 2023 | Reltone 200 Mg, Glycate, Reltone 400 Mg |
| Teleflex LLC | $36.06 | 2023-2024 | Titan Sgs Standard Gastric Stapler, Titan Sgs |
| Mozarc Medical US LLC | $32.55 | 2025 | Palindrome |
| Medline Industries LP | $24.52 | 2024 | Medline Industries, INC. |
| Takeda Pharmaceuticals U.S.A., INC. | $22.98 | 2024 | Gattex |
| Novo Nordisk INC | $19.15 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Debarros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.